ABAXIS, Inc. (ABAX) Set to Announce Quarterly Earnings on Monday
ABAXIS, Inc. (NASDAQ:ABAX) is set to issue its quarterly earnings data after the market closes on Monday, October 23rd. Analysts expect the company to announce earnings of $0.30 per share for the quarter.
ABAXIS (NASDAQ:ABAX) last announced its quarterly earnings data on Thursday, July 27th. The medical research company reported $0.28 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.33 by ($0.05). The business had revenue of $58.26 million during the quarter, compared to the consensus estimate of $60.37 million. ABAXIS had a net margin of 14.12% and a return on equity of 10.85%. The business’s revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.30 EPS. On average, analysts expect ABAXIS to post $1.15 EPS for the current fiscal year and $1.33 EPS for the next fiscal year.
ABAXIS, Inc. (NASDAQ:ABAX) opened at 45.90 on Monday. The company has a market cap of $1.04 billion, a P/E ratio of 32.42 and a beta of 0.82. The firm has a 50-day moving average price of $45.32 and a 200 day moving average price of $48.19. ABAXIS, Inc. has a 12 month low of $43.66 and a 12 month high of $55.95.
A number of equities research analysts have commented on the company. Bank of America Corporation restated an “underperform” rating and issued a $42.00 target price on shares of ABAXIS in a research report on Wednesday, August 23rd. BidaskClub downgraded ABAXIS from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 3rd. Zacks Investment Research downgraded ABAXIS from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. Finally, Stifel Nicolaus restated a “hold” rating and issued a $48.00 target price on shares of ABAXIS in a research report on Friday, July 14th. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. ABAXIS currently has an average rating of “Hold” and a consensus target price of $48.63.
WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/16/abaxis-inc-abax-set-to-announce-quarterly-earnings-on-monday.html.
Abaxis, Inc is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force.
Receive News & Ratings for ABAXIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABAXIS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.